Receive a complimentary business case analysis: our specialty drug cost savings average $18k PMPY for members with autoimmune conditions.
Let's talkRheumatologist shortages in the United States mean long patient waitlists. Once a patient sees a rheumatologist, the appointments are short, and primarily focus on prescribing specialty medication. This results in an average annual payer cost of $63k, including $37k for specialty drugs.
Rheumission's solution averages annual cost savings of $18,450 per patient. We'd love to tell you all about how we achieve these cost savings, along with improved patient outcomes.
* The direct medical cost for RA, PsA, and AS is an estimate calculated using the mean direct medical cost per patient with each condition multiplied by the number of patients. Both the mean medical costs and condition prevalences were obtained from NIH-published research between 2018-2023.
** According to an Autoimmune Association study, the average time it takes for autoimmune patients to receive a diagnosis is 4.6 years (source: Autoimmune.org, 2016). These conditions progress and can cause more damage over time (source: Healthline.com, 2023).
*** The average number of hours missed per week due to high disease activity was calculated based on WPAI baseline survey responses of Rheumission patients in 2024. The Work Productivity and Activity Impairment (WPAI) survey assesses the effect of health problems on one's ability to work and perform regular activities.